IMCD (IMCD) Panoramica del titolo
IMCD N.V. distribuisce, commercializza e vende specialità chimiche e ingredienti nei Paesi Bassi, nel resto d'Europa, in Medio Oriente, Africa, Nord America, Sud America e Asia-Pacifico. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 2/6 |
| Crescita futura | 1/6 |
| Prestazioni passate | 2/6 |
| Salute finanziaria | 3/6 |
| Dividendi | 4/6 |
IMCD Community Fair Values
Create NarrativeSee what 23 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di IMCD N.V.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | €85.50 |
| Massimo di 52 settimane | €116.45 |
| Minimo di 52 settimane | €68.14 |
| Beta | 0.95 |
| Variazione di 1 mese | -3.08% |
| Variazione a 3 mesi | -6.98% |
| Variazione di 1 anno | -23.69% |
| Variazione a 3 anni | -36.48% |
| Variazione a 5 anni | -39.28% |
| Variazione dall'IPO | 282.21% |
Notizie e aggiornamenti recenti
Aggiornamento della narrazione • Jul 09
IMCD: Global Expansion And Dividend Reset Will Support Future Upside
Analysts have modestly lifted the fair value anchor for IMCD, with a price target moving from about €107.68 to €112.50 as they factor in updated assumptions on growth, margins and valuation, alongside mixed recent Street views, including a higher €105 target from Morgan Stanley and a downgrade with a €75 target from JPMorgan. Analyst Commentary Recent research on IMCD points to a split view, with some bullish analysts focusing on valuation support and others, including JPMorgan, highlighting earnings risks and less compelling pricing versus peers.
Aggiornamento della narrazione • Jun 25
IMCD: Dividend Support And Margin Execution Will Drive Future Re Rating Potential
Analysts have marginally lifted their fair value estimate for IMCD to about €148 per share. This reflects a blend of more cautious mid term earnings expectations cited in recent research and a higher Street price target of €105 that still sits well above a more bearish €75 view.Aggiornamento della narrazione • Jun 11
IMCD: Margin Execution And Earnings Quality Will Support Future Re Rating Potential
Analysts have trimmed their fair value estimate for IMCD to about €147.82 from €148.67, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E after recent mixed Street research, including a downgrade to Underweight with a €75 target and a separate target increase to €105. Analyst Commentary Recent research on IMCD points in different directions, with one high profile downgrade and more cautious earnings assumptions on one side, and a higher fair value estimate and an increased price target on the other.
Aggiornamento della narrazione • May 28
IMCD: Fading Middle East Tailwind Will Pressure Future Earnings And Returns
Analysts now see IMCD's fair value at about €76.79, up from €75.00. The shift reflects updated views on earnings potential and valuation following mixed research, including a downgrade to Underweight with a €75 target and a separate price target increase to €105.Aggiornamento della narrazione • May 14
IMCD: Margin Execution And Earnings Quality Should Support Future Re Rating
Narrative update on IMCD The updated analyst price target for IMCD moves to €148.67 from €144.05. This change reflects analysts' revised views on growth, profitability and P/E assumptions after recent target changes from major banks across the sector.Recent updates
Aggiornamento della narrazione • Jul 09
IMCD: Global Expansion And Dividend Reset Will Support Future Upside
Analysts have modestly lifted the fair value anchor for IMCD, with a price target moving from about €107.68 to €112.50 as they factor in updated assumptions on growth, margins and valuation, alongside mixed recent Street views, including a higher €105 target from Morgan Stanley and a downgrade with a €75 target from JPMorgan. Analyst Commentary Recent research on IMCD points to a split view, with some bullish analysts focusing on valuation support and others, including JPMorgan, highlighting earnings risks and less compelling pricing versus peers.Aggiornamento della narrazione • Jun 25
IMCD: Dividend Support And Margin Execution Will Drive Future Re Rating Potential
Analysts have marginally lifted their fair value estimate for IMCD to about €148 per share. This reflects a blend of more cautious mid term earnings expectations cited in recent research and a higher Street price target of €105 that still sits well above a more bearish €75 view.Aggiornamento della narrazione • Jun 11
IMCD: Margin Execution And Earnings Quality Will Support Future Re Rating Potential
Analysts have trimmed their fair value estimate for IMCD to about €147.82 from €148.67, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E after recent mixed Street research, including a downgrade to Underweight with a €75 target and a separate target increase to €105. Analyst Commentary Recent research on IMCD points in different directions, with one high profile downgrade and more cautious earnings assumptions on one side, and a higher fair value estimate and an increased price target on the other.Aggiornamento della narrazione • May 28
IMCD: Fading Middle East Tailwind Will Pressure Future Earnings And Returns
Analysts now see IMCD's fair value at about €76.79, up from €75.00. The shift reflects updated views on earnings potential and valuation following mixed research, including a downgrade to Underweight with a €75 target and a separate price target increase to €105.Aggiornamento della narrazione • May 14
IMCD: Margin Execution And Earnings Quality Should Support Future Re Rating
Narrative update on IMCD The updated analyst price target for IMCD moves to €148.67 from €144.05. This change reflects analysts' revised views on growth, profitability and P/E assumptions after recent target changes from major banks across the sector.Aggiornamento della narrazione • Apr 29
IMCD: Margin Execution And Revenue Mix Should Support Future Re Rating
Analyst price targets for IMCD have edged lower, with recent cuts of €5 to €7 from several banks and a reset range between about €103 and €122. Analysts are factoring in a slightly higher discount rate, a lower assumed future P/E multiple and updated expectations for revenue growth and margins.Aggiornamento della narrazione • Apr 15
IMCD: Dividend Cut And Lowered Expectations Will Pressure Future Returns
IMCD's updated analyst price target has edged lower by a few euros, with recent revisions between about €103 and €122. These reflect analysts' mixed adjustments to growth, margin and P/E assumptions.Aggiornamento della narrazione • Mar 31
IMCD: Lower Dividend And Reset Expectations Will Set Up Future Upside
The Analyst Price Target for IMCD has shifted lower to €107.68 from €126.46, reflecting analysts' updated views on slightly softer revenue growth, thinner profit margins and a lower future P/E multiple, supported by a series of recent price target cuts and one upward revision across major banks. Analyst Commentary Recent research shows a mix of optimism and caution around IMCD, with several banks trimming price targets and one raising them, which helps explain why the average target has reset closer to current expectations.Aggiornamento della narrazione • Mar 17
IMCD: Sector Caution And Dividend Reset Will Shape Future Expectations
Analysts have trimmed the IMCD price target, with recent revisions clustering around €100 to €122. This reflects updated views on sector conditions and modest adjustments to revenue growth, discount rate and profit margin assumptions.Aggiornamento della narrazione • Mar 03
IMCD: Sector Caution And New Partnership Will Shape Future Expectations
The analyst fair value estimate for IMCD has been adjusted from €82.00 to €75.00. Analysts cite recent price target changes across major banks, along with more cautious assumptions on discount rates, revenue growth, and margins, as the key drivers of the updated view.Aggiornamento della narrazione • Feb 17
IMCD: Distribution Expansion And CFO Transition Will Support Future Re Rating
Analysts have trimmed their price targets for IMCD by about €14, citing slightly higher discount rate assumptions, revised profit margin expectations, and recent cautious sector views. These developments are reflected in lower price targets and a downgrade to Equal Weight.Aggiornamento della narrazione • Feb 03
IMCD: Cautious Sector Outlook And New Partnership Will Shape Expectations
Analysts have reduced their fair value estimate for IMCD from €107.00 to €82.00. This reflects a lower future P/E assumption and a slightly reduced profit margin outlook, in line with recent Street research that has turned more cautious on chemical distribution and related services.Aggiornamento della narrazione • Jan 20
IMCD: Distribution Deal And CFO Transition Will Support Sector Re Rating
Analysts have lowered their price target on IMCD to about €170.50 from roughly €176.73, citing a reset in sector expectations following cautious views on chemical distribution and a shift in preferred names within European business services. Analyst Commentary Recent research has shifted IMCD to a more neutral stance within European business services, with the rating moved to Equal Weight and the price target set at €100 from €139.Articolo di analisi • Jan 20
Is There An Opportunity With IMCD N.V.'s (AMS:IMCD) 50% Undervaluation?
Key Insights IMCD's estimated fair value is €148 based on 2 Stage Free Cash Flow to Equity Current share price of...Aggiornamento della narrazione • Jan 06
IMCD: Share Pullback Will Set Up Upside Following New Outperform Coverage
Analysts have trimmed their fair value estimate for IMCD from €127.18 to €126.46, reflecting slightly softer assumptions for revenue growth and profit margin, even as some recent research, including new Outperform coverage, points to potential upside after the recent share pullback. Analyst Commentary Bullish Takeaways Bullish analysts view the recent share pullback as creating a more appealing entry point relative to their updated fair value and the new $72.50 price target.Aggiornamento della narrazione • Dec 17
IMCD Will Likely Gain From New Distribution Deal And Leadership Transition
Analysts have trimmed their fair value estimate for IMCD to approximately €177 from about €182, reflecting slightly higher discount rate assumptions, more moderate revenue growth expectations, and a marginally lower future P/E, partially offset by a firmer margin outlook and recent supportive rating actions despite reduced price targets. Analyst Commentary Bullish analysts continue to frame IMCD as a quality compounder within the specialty chemicals distribution space, highlighting the recent share pullback as an opportunity rather than a sign of structural deterioration.Aggiornamento della narrazione • Dec 03
IMCD: Share Pullback Will Offer Opportunity As New Outperform Ratings Emerge
The analyst price target for IMCD has been trimmed modestly from EUR 131.25 to about EUR 127.18, as analysts factor in slightly slower growth and margin assumptions, even as they highlight recent upgrades and new Outperform initiations as support for a still constructive outlook. Analyst Commentary Recent research updates point to a broadly constructive stance on IMCD, with most commentary emphasizing resilient fundamentals and an attractive entry point following the share price pullback, even as some valuation and macro risks are flagged.Articolo di analisi • Nov 27
Some Shareholders Feeling Restless Over IMCD N.V.'s (AMS:IMCD) P/E Ratio
It's not a stretch to say that IMCD N.V.'s ( AMS:IMCD ) price-to-earnings (or "P/E") ratio of 17.6x right now seems...Aggiornamento della narrazione • Nov 19
IMCD: Share Pullback Will Offer Opportunity As Revenue Momentum Builds
IMCD's analyst price target has been revised down from €138.04 to €131.25. Analysts cite moderate adjustments in fair value and market outlook, despite recent supportive coverage and an improved revenue growth forecast.Articolo di analisi • Nov 12
Does IMCD (AMS:IMCD) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Aggiornamento della narrazione • Nov 04
IMCD: Share Price Pullback Will Offer Attractive Entry As Ratings Improve
The analyst fair value estimate for IMCD has been reduced from EUR 142.43 to EUR 138.04. Analysts cite more cautious assumptions on long-term revenue growth and profit margin forecasts following recent price target adjustments in Street research.Articolo di analisi • Oct 28
At €93.80, Is IMCD N.V. (AMS:IMCD) Worth Looking At Closely?
IMCD N.V. ( AMS:IMCD ), might not be a large cap stock, but it saw significant share price movement during recent...Aggiornamento della narrazione • Oct 21
Analyst Commentary Highlights Mixed Views on IMCD Amid Minor Valuation Adjustments
Analysts have slightly lowered their fair value estimate for IMCD by less than 1 percent to approximately €142.43. This reflects minor adjustments in growth expectations and recent Street research supporting a cautiously positive outlook, despite recent target downgrades.Articolo di analisi • Oct 12
Returns On Capital At IMCD (AMS:IMCD) Have Hit The Brakes
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...Aggiornamento della narrazione • Oct 03
Digitalization And M&A Will Expand Pharma And Consumer Markets
IMCD's analyst price target has decreased moderately, from €145.43 to €143.00, as analysts factor in slightly lower expected growth and a reduced profit margin outlook in recent industry assessments. Analyst Commentary Analyst opinions on IMCD remain divided as recent price target changes and rating updates reflect a mix of optimism regarding potential growth and caution due to evolving sector dynamics.Aggiornamento della narrazione • Sep 04
Digitalization And M&A Will Expand Pharma And Consumer Markets
Analysts cite attractive valuation, improved capital allocation, and stabilizing end markets as supportive, but near-term earnings uncertainty and ongoing macroeconomic headwinds have kept IMCD’s consensus price target unchanged at €145.43. Analyst Commentary Valuation now seen as attractive, with shares offering growth at a reasonable price.Articolo di analisi • Sep 01
An Intrinsic Calculation For IMCD N.V. (AMS:IMCD) Suggests It's 44% Undervalued
Key Insights The projected fair value for IMCD is €170 based on 2 Stage Free Cash Flow to Equity IMCD is estimated to...Articolo di analisi • Aug 04
We Think IMCD (AMS:IMCD) Can Stay On Top Of Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Articolo di analisi • Jul 21
There's Reason For Concern Over IMCD N.V.'s (AMS:IMCD) Price
IMCD N.V.'s ( AMS:IMCD ) price-to-earnings (or "P/E") ratio of 23.9x might make it look like a sell right now compared...
Nuova narrazione • Nov 25
The Company'S Digital Upgrades And M&A Strategy Ignite Growth Potential Amid Challenges
Continued organic growth through commercial excellence and digital upgrades could boost future revenue and earnings.Rendimenti per gli azionisti
| IMCD | NL Trade Distributors | NL Mercato | |
|---|---|---|---|
| 7D | 2.4% | -2.1% | 0.7% |
| 1Y | -23.7% | 2.8% | 37.8% |
Ritorno vs Industria: IMCD ha avuto una performance inferiore rispetto al Dutch Trade Distributors che ha registrato un rendimento 2.8 % nell'ultimo anno.
Rendimento vs Mercato: IMCD ha avuto una performance inferiore al mercato Dutch che ha registrato un rendimento 37.8 % nell'ultimo anno.
Volatilità dei prezzi
| IMCD volatility | |
|---|---|
| IMCD Average Weekly Movement | 4.1% |
| Trade Distributors Industry Average Movement | 4.8% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in NL Market | 7.4% |
| 10% least volatile stocks in NL Market | 2.2% |
Prezzo delle azioni stabile: IMCD non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato Dutch.
Volatilità nel tempo: La volatilità settimanale ( 4% ) di IMCD è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1995 | 5,246 | Marcus Jordan | www.imcdgroup.com |
IMCD N.V. distribuisce, commercializza e vende specialità chimiche e ingredienti nei Paesi Bassi, nel resto d'Europa, in Medio Oriente, Africa, Nord America, Sud America e Asia-Pacifico. L'azienda fornisce adesivi, materiali di base, rinforzi di riempimento, ritardanti di fiamma, masterbatch, modificatori, materiali operativi, pigmenti, plastificanti, coadiuvanti tecnologici, materie prime PUR, elastomeri di gomma, solventi, stabilizzatori, elastomeri termoplastici, termoplastici, termoplastici e altri additivi. Offre principi attivi, filtri solari UV, modificatori reologici, addensanti, tensioattivi, emulsionanti, emollienti, filmogeni, umettanti, cere, balsami, polimeri per l'acconciatura, solventi, solubilizzanti, pigmenti, perle, polveri e coloranti, opacizzanti, perlanti, conservanti, antiossidanti, fragranze e oli essenziali.
IMCD N.V. Riepilogo dei fondamenti
| IMCD statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | €5.05b |
| Utili (TTM) | €217.58m |
| Ricavi(TTM) | €4.81b |
23.2x
Rapporto P/E1.1x
Rapporto P/SIMCD è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| IMCD Conto economico (TTM) | |
|---|---|
| Ricavi | €4.81b |
| Costo del fatturato | €3.59b |
| Profitto lordo | €1.22b |
| Altre spese | €1.00b |
| Utili | €217.58m |
Ultimi utili riportati
Dec 31, 2025
Prossima data di guadagno
Jul 29, 2026
| Utile per azione (EPS) | 3.69 |
| Margine lordo | 25.38% |
| Margine di profitto netto | 4.53% |
| Rapporto debito/patrimonio netto | 82.6% |
Come si è comportato IMCD nel lungo periodo?
Vedi performance storica e confrontoDividendi
2.1%
Rendimento attuale del dividendo49%
Rapporto di remunerazioneAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/07/10 01:58 |
| Prezzo dell'azione a fine giornata | 2026/07/10 00:00 |
| Utili | 2025/12/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; disponiamo inoltre di guide su come utilizzare i nostri report e di tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
IMCD N.V. è coperta da 22 analisti. 12 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Gaurav Jain | Barclays |
| James Stewart | Barclays |
| Anil Shenoy | Barclays |